Filters

Robert C Bruce, Nicholas B Guros, Son T Le, Antonio Cardone, Arvind Balijepalli, Curt A Richter, Harish C Pant, Jeffery B Klauda, Siyuan Zhang, Niranjana D Amin

Nanoscale 2020;11(33):15622-15632

Free Full Text

Abstract

CDKAL1-related single nucleotide polymorphisms are associated with insulin resistance in a cross-sectional cohort of Greek children.

Mathias Rask-Andersen, Gaëtan Philippot, George Moschonis, George Dedoussis, Yannis Manios, Claude Marcus, Robert Fredriksson, Helgi B Schiöth

PloS one 2015;9(4):e93193

Free Full Text

Abstract

DrugScoreRNA--knowledge-based scoring function to predict RNA-ligand interactions.

Patrick Pfeffer, Holger Gohlke

Journal of chemical information and modeling 2007;47(5):1868-76

Full Text

Abstract

Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.

Abdelhamid Barakat, Sonia Abdelhak, Hassan Rouba, Malika Fakiri, Rym Kefi-Ben Atig, Redouane Boulouiz, Khaled Lasram, Hicham Charoute, Houda Benrahma

Biochemical genetics 2015;52(9-10):430-42

Full Text

Abstract

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

Anne Jämsä, Kristina Hasslund, Richard F Cowburn, Anders Bäckström, Mervi Vasänge

Biochemical and biophysical research communications 2004;319(3):993-1000

Full Text

Abstract

An evaluation of indirubin analogues as phosphorylase kinase inhibitors.

Colin Moffatt, Joseph M Hayes, Nikos G Oikonomakos, Demetres D Leonidas, Alexios-Leandros Skaltsounis, Josephine Sarrou, Nicolas Bischler, Vassiliki T Skamnaki, Jaida Begum

Journal of molecular graphics & modelling 2016;61():231-42

Full Text

Abstract

Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Giorgio Sesti, Gaia Chiara Mannino

Molecular diagnosis & therapy 2013;16(5):285-302

Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cyclin-Dependent Kinase 5""[mesh_terms]

The role of cyclin-dependent kinase 5 in neuropathic pain.

An in-silico study to identify potent phytochemicals for reducing neurotoxicity triggered by calpain and CDK5/p25 complex.

De Novo Rational Design of Peptide-Based Protein-Protein Inhibitors (Pep-PPIs) Approach by Mapping the Interaction Motifs of the PP Interface and Physicochemical Filtration: A Case on p25-Cdk5-Mediated Neurodegenerative Diseases.

Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.

Gestational Diabetes and Genetics: MTNR1B, CDKAL1, and IRS1 as Critical Players.

CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.

Bioinformatic prediction and confirmation of beta-adducin as a novel substrate of glycogen synthase kinase 3.

Synergic effect of retinoic acid and extremely low frequency magnetic field exposure on human neuroblastoma cell line BE(2)C.

Quantum capacitance-limited MoS biosensors enable remote label-free enzyme measurements.

CDKAL1-related single nucleotide polymorphisms are associated with insulin resistance in a cross-sectional cohort of Greek children.

DrugScoreRNA--knowledge-based scoring function to predict RNA-ligand interactions.

Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

An evaluation of indirubin analogues as phosphorylase kinase inhibitors.

Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Results for
""Cyclin-Dependent Kinase 5""[mesh_terms]